Immunocellular Therapeutics, Ltd. (IMUC) Reports Q3 Loss of $0.02

November 12, 2012 6:42 AM

Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q3 EPS of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found